Cellestia Biotech raises CHF 20 million a series B round

Cellestia Biotech raises CHF 20 million a series B round

17.12.2019 – Cellecia Biotech has closed a CHF 20 million series B round led by FC Capital, Shanghai. The new funds bring the company’s total investment to-date to CHF 49 million. The funds will be used to finance the operations and to advance the ongoing Phase l clinical trial into Phase II.

read more on startupticker